Medications

Learn what are Xanax Withdrawal Symptoms, how long Xanax withdrawal symptoms last and why first few hour of quiting Xanax (alprazolam) should be critical monitored by the physician. Xanax (alprazolam) is a benzodiazepine class of drugs that reduce the over-activity in the brain and central nervous system by mounting the ...

Darzalex/daratumumab side effects, cost, dosage for multiple myeloma. Darzalex is marketed by Janssen Biotech of Horsham, Pennsylvania. FDA approved new drug Darzalex for patients suffering from multiple myeloma on November 16, 2015. Daratumumab is active ingredient of this drug. FDA indicated this drug for treatment of patients with multiple myeloma who have received ...

Orkambi, breakthrough drugs for Cystic Fibrosis treatment was approved by FDA approved in 2015. Orkambi is orally-delivered medicine in the form of fully co-formulated tablets i.e. a combination therapy that contains two drugs lumacaftor and ivacaftor. Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) is a protein that is responsible for regulating ...

Nucala/Mepolizumab Side effects, Cost, Dosage for Asthma. Nucala is marketed by GSK. Nucala mepolizumab is approved by FDA on 4th November 2015.Nucala mepolizumab is an interleukin-5 adversary monoclonal antibody (IgG1 kappa) demonstrated for the extra support or add-on treatment of patients with serious eosinophilic asthma. Nucala is a physician recommended ...

Yondelis/Trabectedin Side effects, Cost, Dosage for Leiomyosarcoma and Liposarcoma.Yondelis is marketed by Janssen Products of Raritan, New Jersey. yondelis for Leiomyosarcoma and Liposarcoma. Yondelis/trabectedin is first approved by FDA on 23rd October 2015.Yondelis trabectedin is chemotherapy for the treatment of particular type of soft tissue sarcomas (STS) – liposarcoma and leiomyosarcoma – ...

Strensiq/Asfotase Alfa Side effects, Cost, Dosage for Hypophosphatasia. Strensiq is marketed by Alexion pharmaceuticals. Strensiq is approved by FDA on 23rd October 2015.Its active ingredient is asfotase alfa.Strensiq asfotase alfa is used as the initially endorsed treatment for perinatal, infantile and juvenile onset hypophosphatasia (HPP). HPP is an uncommon, hereditary, progressive, ...

The population of HIV patient has grown; there is an increased risk for development of treatment-related co morbidities, including low bone mineral density and renal mutilation. But now the world have a solution against such a terrible problem termed as HIV in the form of Genvoya, which has developed from ...

Imlygic/Talimogene Laherparepvec Side effects, Cost, Dosage for Melanoma, FDA approval, Mechanism, Clinical trials. Imlygic is marketed by BioVex Inc., a subsidiary of Amgen Inc. The U.S. Food and Drug Administration approved Imlygic (talimogene laherparepvec) on 27th October 2015, the first FDA-approved oncolytic virus therapy, for the treatment of melanoma lesions in the ...

Secukinumab (Cosentyx) cost, dosing and side effects as new FDA approved medicine for psoriatic arthritis treatment by East Hanover, New Jersey-based Novartis Pharmaceuticals Corporation. Cosentyx also known as secukinumab is a new medicine was approved by US Food and Drug Administration (FDA) and the European Commission in January 2015. Inactive ...

Visitors

Subscribe

Disclaimers

HealthnCare.Info is protected under DMCA laws. Republishing of its contents, without Permission or provision of credit or citation to the original article is liable to legal action with DCMA, Chilling Effects, Webhost and Google to take down.

Product Trademarks

All brands, trademarks, service marks, logos, product labels and packing images displayed on this website, are registered to the respective owner. Their use or mentioning on this website is only for informational purposes.